Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dean

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
Brain Research|September 10, 2008
Molecular profiles of schizophrenia in the CNS at different stages of illnessSujatha Narayan, Bin Tang, Steven R Head, et al.
Bioanalysis|October 21, 2011
Evaluation of dried blood spot sampling following cassette dosing in drug discoveryXiaorong Liang, Lulu Yang, Leonid Berezhkovskiy, et al.
The International Journal of Neuropsychopharmacology|September 26, 2013
Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think TankBrian Dean, Hans-Jürgen Moller, Torgny H Svensson, et al.
The International Journal of Neuropsychopharmacology|April 23, 2015
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think TankElizabeth Scarr, Mark J Millan, Sabine Bahn, et al.
The International Journal of Neuropsychopharmacology|August 8, 2007
Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophreniaShirly Amar, Galit Shaltiel, Liad Mann, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 22, 2013
Solvent-based formulations for intravenous mouse pharmacokinetic studies: tolerability and recommended solvent dose limitsEvan A Thackaberry, Xiaojing Wang, Michelle Schweiger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 8, 2009
Decreased kainate receptors in the hippocampus of apolipoprotein D knockout miceSimone Boer, Diego Sanchez, Ivo Reinieren, et al.
Psychiatry Research. Neuroimaging|December 6, 2024
Glutamate concentrations and cognitive deficits in ultra-treatment-resistant schizophrenia: An exploratory and comparative <sup>1</sup>H-MRS studyJamie J Lopes, Caroline D Rae, Denny Meyer, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 22, 2012
Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0879 and its metabolite in dog plasma using solid phase extractionBilin Chou, Ryan S Adler, Min Meng, et al.
Journal of Psychiatry & Neuroscience : JPN|June 1, 2018
Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophreniaElizabeth Scarr, Shaun Hopper, Valentina Vos, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
Brain Research|September 10, 2008
Molecular profiles of schizophrenia in the CNS at different stages of illnessSujatha Narayan, Bin Tang, Steven R Head, et al.
Bioanalysis|October 21, 2011
Evaluation of dried blood spot sampling following cassette dosing in drug discoveryXiaorong Liang, Lulu Yang, Leonid Berezhkovskiy, et al.
The International Journal of Neuropsychopharmacology|September 26, 2013
Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think TankBrian Dean, Hans-Jürgen Moller, Torgny H Svensson, et al.
The International Journal of Neuropsychopharmacology|April 23, 2015
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think TankElizabeth Scarr, Mark J Millan, Sabine Bahn, et al.
The International Journal of Neuropsychopharmacology|August 8, 2007
Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophreniaShirly Amar, Galit Shaltiel, Liad Mann, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 22, 2013
Solvent-based formulations for intravenous mouse pharmacokinetic studies: tolerability and recommended solvent dose limitsEvan A Thackaberry, Xiaojing Wang, Michelle Schweiger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 8, 2009
Decreased kainate receptors in the hippocampus of apolipoprotein D knockout miceSimone Boer, Diego Sanchez, Ivo Reinieren, et al.
Psychiatry Research. Neuroimaging|December 6, 2024
Glutamate concentrations and cognitive deficits in ultra-treatment-resistant schizophrenia: An exploratory and comparative <sup>1</sup>H-MRS studyJamie J Lopes, Caroline D Rae, Denny Meyer, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 22, 2012
Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0879 and its metabolite in dog plasma using solid phase extractionBilin Chou, Ryan S Adler, Min Meng, et al.
Journal of Psychiatry & Neuroscience : JPN|June 1, 2018
Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophreniaElizabeth Scarr, Shaun Hopper, Valentina Vos, et al.
Pageof 25